Ionis Pharmaceuticals Inc (NASDAQ:IONS)

49.88
Delayed Data
As of 4:15pm ET
 +0.02 / +0.04%
Today’s Change
37.26
Today|||52-Week Range
65.51
-0.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues147.3M214.2M283.7M346.6M
 
 
 
 
 
Depreciation And Amortization9.8M9.4M10.2M9.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses189.2M252.5M349.2M381.6M
 
 
 
 
 
Research And Development181.6M239.5M319.4M341.8M
 
 
 
 
 
Total Operating Expenses199.0M261.9M359.5M390.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-51.7M-47.7M-75.8M-44.0M
 
 
 
 
 
Extraordinary Charge0.00-8.3M0.00-6.3M
 
 
 
Interest Expense On Debt19.4M22.2M36.7M38.8M
 
 
 
 
 
Other Expenses2.4M21.2M20.3M56.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-66.6M-54.4M-87.9M-83.6M
 
 
 
 
 
Income Taxes-5.9M-15.4M-372.0K-2.9M
 
 
 
 
 
Net Income-60.6M-39.0M-88.3M-86.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS110.5M117.7M119.7M120.9M
 
 
 
 
 
Shares To Calculate EPS Diluted110.5M117.7M119.7M120.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.55-$0.33-$0.74-$0.72
 
 
 
 
 
EPS Diluted-$0.55-$0.33-$0.74-$0.72